{"id":14409,"date":"2026-05-15T15:12:21","date_gmt":"2026-05-15T15:12:21","guid":{"rendered":"https:\/\/www.europesays.com\/germany\/14409\/"},"modified":"2026-05-15T15:12:21","modified_gmt":"2026-05-15T15:12:21","slug":"pharmalittle-u-s-pressuring-germany-on-drug-prices","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/germany\/14409\/","title":{"rendered":"Pharmalittle: U.S. pressuring Germany on drug prices"},"content":{"rendered":"

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up, but we expect to drop in at a few musical happenings, promenade with the official mascots, and hang with the Pharmalot ancestor. We also will be making time for yet another listening party, where the rotation will likely include this<\/a>, this<\/a>, this<\/a>, this<\/a> and this<\/a>. And what about you? Once again, we will remind you that this is a fabulous time to enjoy the great outdoors. An added bonus, of course, is you can get some exercise, too. If the weather fails to cooperate, though, you could visit your local library and curl up with a good book. Or take in a moving picture show at whatever cinema may still exist in your part of the world. If none of this sounds appealing, well, you could simply plan the rest of your life. Whatever you do, have a grand time. But be safe. Enjoy, and see you soon \u2026<\/p>\n

Over a recent breakfast, U.S. officials had a message for the German ambassador: pay more for pharmaceuticals, STAT<\/a> reports. The meeting, between U.S. Trade Representative Jamieson Greer, chief health department adviser Chris Klomp, and German Ambassador Jens Hanefeld, was part of a larger push from the Trump administration to get other countries to pay more for medications as the U.S. pays less, according to a person familiar with the meeting. The U.S. officials discussed the possible use of tariffs under Section 301, which grants the government authority to combat trade practices considered \u201cunfair.\u201d The move would be similar to the tactic of threatening new tariffs to get other countries to pay more for drugs. The ambassador agreed to review the matter with officials in Germany, but no deal was made.<\/p>\n

Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry grows that layoffs and policy changes at the drugs watchdog under the Trump administration may delay regulatory reviews, according to Reuters<\/a>. Mass layoffs, leadership exits, and the restructuring of the FDA under President Trump are prompting some smaller biotechs to rethink traditional pathways for bringing new medicines to market. Reuters spoke to seven biotech executives, investors, and consultants who said that the staff departures and policy changes at the FDA had prompted some firms to consider launching trials in other international markets \u2014 such as the European Union and Australia \u2014 and engaging with regulators in those regions earlier in the drug development process.<\/p>\n

STAT+ Exclusive Story<\/p>\n

Already have an account? Log in<\/a><\/p>\n

\t\t\t\"STAT+\"\/<\/p>\n

\t\t\t\t\t
\n\t\t\t\t\t\t\"STAT+\"\/
\n\t\t\t\t\t<\/a><\/p>\n

\t\t\t\tThis article is exclusive to STAT+ subscribers
\n\t\t\t\tUnlock this article \u2014 plus in-depth analysis, newsletters, premium events, and news alerts.<\/p>\n

Already have an account? Log in<\/a><\/p>\n

\t\t\t\t\t\tIndividual plans<\/p>\n

\t\t\t\t\t\tGroup plans<\/p>\n

\t\t\t\tView All Plans<\/a><\/p>\n

\n\t\t\t\t\t\tTo read the rest of this story subscribe to STAT+.\t\t\t\t\t<\/p>\n

\t\t\t\t\tSubscribe<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"And so, another working week will soon draw to a close. Not a moment too soon, yes? This…\n","protected":false},"author":2,"featured_media":14410,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[5,18472,17988],"class_list":{"0":"post-14409","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-germany","8":"tag-germany","9":"tag-pharmalittle","10":"tag-stat"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/posts\/14409","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/comments?post=14409"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/posts\/14409\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/media\/14410"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/media?parent=14409"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/categories?post=14409"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/germany\/wp-json\/wp\/v2\/tags?post=14409"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}